Hospice News June 24, 2020
While private equity interest in the hospice space remains hot, some players have abandoned or postponed plans to bring their holdings to the acquisitions market during the COVID-19 pandemic. While many expect the market to rebound by the third or fourth quarter of the year, nothing is certain as COVID cases continue to spike throughout the United States.
A number of factors have whetted the appetites of private equity firms for hospice in recent years, including the fragmented nature of the industry, increased acceptance of palliative care services, demographic tailwinds, the changing regulatory landscape, and movement towards value-based payment models.
In the long term, these investors are unlikely to lose interest, though specific transactions may see further delays due to...